NGAClass I
Test, Follicle Stimulating Hormone (Fsh), Over The Counter
21 CFR 862.1300 / Clinical Chemistry
NGA is the FDA product code for Test, Follicle Stimulating Hormone (Fsh), Over The Counter, a class I device type, regulated under 21 CFR 862.1300. As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and 2 recalls.
Classification record
- Product code
- NGA
- Device name
- Test, Follicle Stimulating Hormone (Fsh), Over The Counter
- Regulation
- 21 CFR 862.1300
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 2
Clearances, product code NGA
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
Applicants with the most clearances
Product code NGA| Applicant | Clearances |
|---|---|
| Genosis, Ltd. | 1 |
| Quantrx Biomedical Corporation | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this code- Abbott Diagnostics (Shanghai) Co., Ltd.
- Aceso Laboratories Inc.
- ACRO BIOTECH Inc.
- Alfa Scientific Designs, Inc.
- Anhui Deepblue Medical Technology Co., Ltd.
- Assure Tech LLC
- Assure Tech. (Hangzhou) Co., Ltd.
- Biobase Biodustry(shandong)co., Ltd
- Bioteke Corporation (Wuxi) Co., Ltd
- BTNX Inc.
- Changchun LYZ Technology Co.,LTD
- Changchun Merydi Bio-Tech Co., Ltd.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
